ADIPOQ and steatosis: PEA, a non-canonic endocannabinoid, is recognized as an insulin sensitizer and AMPK activator, able to improve hepatic lipid and glucose homeostasis, steatosis, insulin resistance and serum leptin/adiponectin ratio [12].